Get In Touch with GateHouse Bio (fka sRNAlytics)
Please tell us a little bit about yourself and why you'd like to get connected. GateHouse Bio (fka sRNAlytics) + SOSV will follow up with you via email.
Breaking RNA codes to enable precision sRNA medicine
Gatehouse Bio unlocks disease-driving RNA codes to power precision sRNA medicine. Its Code-Breaker™ platform maps complex mRNA::sRNA activity relationships to identify biomarkers and drug targets. The company partners to co-develop targeted therapeutics and move its first lead into human clinical trials.
It takes over 4 years and dozens of tests to even diagnose it, and even those are wrong... One in four patients in dementia clinical trials don't even have early-stage dementia, and leads to the 99% drug failure rate.
I left my job at Biogen to pursue a vision to turn small RNAs into the next generation biomarkers.
Please tell us a little bit about yourself and why you'd like to get connected. GateHouse Bio (fka sRNAlytics) + SOSV will follow up with you via email.
No Offer, Solicitation, Advice, or Recommendation
Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.